Literature DB >> 16610709

Cytokines as mediators and targets for cancer cachexia.

Josep M Argilés1, Sílvia Busquets, Francisco J López-Soriano.   

Abstract

The cachexia syndrome, characterized by a marked weight loss, anorexia, asthenia and anaemia, is invariably associated with the growth of a tumour and leads to a malnutrition status caused by the induction of anorexia or decreased food intake. In addition, the competition for nutrients between the tumour and the host results in a state of accelerated catabolism, which promotes severe metabolic disturbances in the patient. The search for the cachectic factor(s) started a long time ago, and many scientific and economic efforts have been devoted to its discovery, but we are still a long way from a complete answer. The present review aims to evaluate the different molecular mechanisms and catabolic mediators (both humoural and tumoural) that are involved in cancer cachexia and to discuss their potential as targets for future clinical investigations.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16610709     DOI: 10.1007/0-387-26283-0_9

Source DB:  PubMed          Journal:  Cancer Treat Res        ISSN: 0927-3042


  14 in total

1.  Formoterol and cancer muscle wasting in rats: Effects on muscle force and total physical activity.

Authors:  Sílvia Busquets; Míriam Toledo; Sònia Sirisi; Marcel Orpí; Roberto Serpe; Joana Coutinho; Raquel Martínez; Josep M Argilés; Francisco J López-Soriano
Journal:  Exp Ther Med       Date:  2011-04-28       Impact factor: 2.447

2.  Prognostic value of an inflammation-based score in patients undergoing pre-operative chemotherapy followed by surgery for esophageal cancer.

Authors:  Hiroshi Miyata; Makoto Yamasaki; Yukinori Kurokawa; Shuji Takiguchi; Kiyokazu Nakajima; Yoshiyuki Fujiwara; Masaki Mori; Yuichiro Doki
Journal:  Exp Ther Med       Date:  2011-06-30       Impact factor: 2.447

3.  Association of interleukin-6 polymorphisms with susceptibility to hepatocellular carcinoma.

Authors:  Xiaohuan Zheng; Cuiping Han; Rong Shan; Haitao Zhang; Zhaomin Zheng; Yuanshui Liu; Aiguang Wang
Journal:  Int J Clin Exp Med       Date:  2015-04-15

4.  Management of colorectal cancer patients after resection of liver metastases: can we offer a tailored treatment?

Authors:  Miriam López-Gómez; Paloma Cejas; María Merino; David Fernández-Luengas; Enrique Casado; Jaime Feliu
Journal:  Clin Transl Oncol       Date:  2012-08-22       Impact factor: 3.405

Review 5.  Pathophysiology of cancer-related fatigue.

Authors:  Xin Shelley Wang
Journal:  Clin J Oncol Nurs       Date:  2008-10       Impact factor: 1.027

6.  Effects of glucocorticoids on weight change during the treatment of Wegener's granulomatosis.

Authors:  Peter K Wung; Troy Anderson; Kevin R Fontaine; Gary S Hoffman; Ulrich Specks; Peter A Merkel; Robert Spiera; John C Davis; E William St Clair; W Joseph McCune; John H Stone
Journal:  Arthritis Rheum       Date:  2008-05-15

7.  Cachexia and aging: an update based on the Fourth International Cachexia Meeting.

Authors:  J E Morley; S D Anker; W J Evans
Journal:  J Nutr Health Aging       Date:  2009-01       Impact factor: 4.075

8.  Nuclear magnetic resonance in conjunction with functional genomics suggests mitochondrial dysfunction in a murine model of cancer cachexia.

Authors:  Caterina Constantinou; Cibely Cristine Fontes de Oliveira; Dionyssios Mintzopoulos; Silvia Busquets; Jianxin He; Meenu Kesarwani; Michael Mindrinos; Laurence G Rahme; Josep M Argilés; A Aria Tzika
Journal:  Int J Mol Med       Date:  2010-11-10       Impact factor: 4.101

9.  Proteomic profiling of the hypothalamus in a mouse model of cancer-induced anorexia-cachexia.

Authors:  R Ihnatko; C Post; A Blomqvist
Journal:  Br J Cancer       Date:  2013-09-03       Impact factor: 7.640

10.  Pathophysiological role of hormones and cytokines in cancer cachexia.

Authors:  Hyun Jung Kim; Han Jo Kim; Jina Yun; Kyoung Ha Kim; Se Hyung Kim; Sang-Cheol Lee; Sang Byung Bae; Chan Kyu Kim; Nam Su Lee; Kyu Taek Lee; Seong Kyu Park; Jong Ho Won; Hee Sook Park; Dae Sik Hong
Journal:  J Korean Med Sci       Date:  2012-01-27       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.